adenosine has been researched along with Graft-Versus-Host Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Amaral, IPG; Araújo, JMG; de Sousa Dias, CN; de Sousa Palmeira, PH; Gois, BM; Guerra-Gomes, IC; Keesen, TSL; Peixoto, RF | 1 |
| Alahmari, B; Choi, J; Cooper, M; DiPersio, JF; Ritchey, J; Ziga, E | 1 |
| Adhikary, SR; Geraghty, NJ; Sluyter, R; Watson, D | 1 |
| Li, L; Rong, R; Wang, J; Xu, M; Zhu, T | 1 |
| Tsukamoto, H | 2 |
| Zeiser, R | 1 |
| Amarnath, S; Barrett, AJ; Battiwalla, M; Chinnassamy, D; Keyvanfar, K; Muranski, P; Whitehill, GD | 1 |
| Enk, AH; Johnson, TS; Karakhanova, S; Mahnke, K; Näher, H; Schmitt, S | 1 |
| Chinnaiyan, AM; He, S; Kato, K; Kuick, R; Liu, Y; Mani, RS; Marquez, VE; Mineishi, S; Mochizuki, K; Nieves, E; Varambally, S; Wang, J; Xie, F; Zhang, Y | 1 |
| Anderlini, P; Andersson, BS; Andreeff, M; Braunschweig, I; Bruton, J; Champlin, R; Claxton, D; Cohen, A; Davis, M; Donato, M; Gajewski, J; Giralt, S; Ippolitti, C; Khouri, I; Kornblau, S; Molldrem, J; Przepiorka, D; Thall, PF; Ueno, NT; Wang, X | 1 |
3 review(s) available for adenosine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
[Extracellular adenosine is a therapeutic target for limiting graft-versus-host disease and enhancing the graft-versus-tumor effect against hematopoietic malignancy].
Topics: 5'-Nucleotidase; Adenosine; Animals; Extracellular Space; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans | 2014 |
[Immune regulation via the generation of extracellular adenosine by CD73].
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Graft vs Host Disease; Humans; Neoplasms; Receptors, Purinergic P1; T-Lymphocytes, Regulatory | 2014 |
Activation of Innate Immunity in Graft-versus-Host Disease: Implications for Novel Targets?
Topics: Adenosine; Graft vs Host Disease; Humans; Immunity, Innate | 2015 |
1 trial(s) available for adenosine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Topics: Acute Disease; Adenosine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cladribine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2001 |
7 other study(ies) available for adenosine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Downregulation of CD73 on CD4+ T cells from patients with chronic Chikungunya infection.
Topics: Adenosine; Adenosine Triphosphate; Animals; Apyrase; CD4-Positive T-Lymphocytes; Chikungunya Fever; Down-Regulation; Graft vs Host Disease; Humans | 2022 |
Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation.
Topics: Adenosine; Animals; Benzamides; Biphenyl Compounds; Cells, Cultured; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histone Code; Histones; Humans; Indoles; Methylation; Mice; Morpholines; Pyridones; T-Lymphocytes | 2018 |
The A
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Body Weight; Cytokines; Disease Models, Animal; Female; Graft vs Host Disease; Humans; Mice; Phenethylamines; T-Lymphocytes, Regulatory | 2019 |
Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.
Topics: Adenosine; Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Fas Ligand Protein; Female; Graft vs Host Disease; Granzymes; Hematopoietic Stem Cell Transplantation; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Male; Methylation; Mice; Mice, Inbred C3H; T-Lymphocytes, Cytotoxic; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Transplantation Chimera; Transplantation Tolerance; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2013 |
Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cell Survival; Graft vs Host Disease; Haplotypes; Humans; Immunity; Leukemia; Lymphocyte Depletion; Lymphocyte Subsets; Middle Aged; T-Cell Antigen Receptor Specificity; T-Lymphocytes; Tissue Donors; Viruses; Young Adult | 2016 |
Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Topics: Adenosine; Antigens, CD; Apyrase; Case-Control Studies; CD8-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Female; Forkhead Transcription Factors; Graft vs Host Disease; Humans; Immunophenotyping; Immunosuppression Therapy; Interleukin-2 Receptor alpha Subunit; Lipopolysaccharide Receptors; Lymphocyte Activation; Male; Photopheresis; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Time Factors | 2009 |
Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.
Topics: Adenosine; Animals; Apoptosis; Cells, Cultured; Disease Progression; Enzyme Inhibitors; Graft vs Host Disease; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Isoantigens; Lymphocyte Activation; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Substrate Specificity; T-Lymphocytes; Up-Regulation | 2012 |